Puro Risk Insights Blog
Our blog is an educational hub for clear and timely insights on the cannabis and hemp industry.
We simplify insurance topics regulatory updates and real world risks into easy to understand content for operators at every stage.
From cultivation to retail we provide practical guidance coverage education and market insights to help you stay compliant protected and informed so you can make smarter and more confident decisions.
ON THE BLOG
CATEGORIES
FEATURED POST
Recent Industry Updates
All Articles
Browse our complete collection of cannabis and hemp insights below. This page brings together all published articles covering policy and regulation, business and economy, legal and justice, industry innovation, and culture and community. Each post is created to educate and inform operators and industry stakeholders by breaking down complex topics into clear, practical insights. Scroll down to explore the full library and stay informed on the issues shaping the industry.
Curaleaf Uplisting Push Shows Cannabis Capital Markets Are Starting To Move
Curaleaf is preparing for a possible U.S. stock exchange uplisting by executing a 1 for 3 reverse stock split expected around June 5. The bigger lesson is that public cannabis companies are positioning for better capital access, but uplisting still depends on regulatory movement, exchange rules, and institutional investor appetite.
Global Cannabis Pricing Compression Is The Emerging Market Warning Sign
A new GCNC and Whitney Economics report examines how pricing compression is reshaping cannabis markets across North America, Europe, Latin America, and Israel. The bigger lesson is that emerging markets can look attractive early, but operators and investors need to model margin pressure before supply expands and prices fall.
Louisiana Medical Cannabis Retail Expansion Shows A Tight Market Still Has Room To Grow
Louisiana medical cannabis retail access continues to expand with a new NOLA Cannabis Co. dispensary in Harvey. The bigger lesson is that patient growth, retail convenience, and local market positioning still matter in a tightly controlled limited license market.
Organigram Sees Germany As A Launchpad For European Expansion
Organigram is using Germany as its first real step into broader European medical cannabis growth. The bigger lesson for operators is that international expansion still depends on local compliance, strong distribution partners, and the patience to build market by market.
Auxly’s Q1 Growth Shows How Taxes Still Squeeze Cannabis Operators
Auxly reported higher Q1 2026 revenue driven by flower and pre roll sales, but the bigger business lesson is tax pressure. The company incurred just under $20 million in excise taxes on $59.7 million in cannabis product sales, showing why operators need to track product mix, pricing, and cash flow beyond top line growth.
Fluent’s New York Closure Shows Growth Does Not Always Mean Profitability
Fluent owned Etain is closing its Chestertown cultivation and packaging facility ahead of Vireo Growth’s planned acquisition of Fluent. The bigger lesson is that New York cannabis may be growing on paper, but operators still need cost discipline, cash flow control, and a clear plan for facilities that no longer fit the strategy.
Cannabis License Decline Shows The Easy Expansion Era Is Over
Active U.S. cannabis business licenses fell to 36,169 in the first quarter of 2026, extending a seven quarter decline. The bigger lesson for operators is that market access, renewals, capital planning, and survival margins now deserve more attention than expansion headlines.
Curaleaf’s Florida Expansion Shows The Race For Patient Access Is Still On
Curaleaf’s latest Florida expansion is another sign that large operators are still racing to lock in patient access and local market share. The bigger lesson is that in limited access medical markets, storefront growth is a long term positioning play, not just a short term retail story.
Target’s Hemp THC Drink Expansion Raises Bigger Questions For Operators
Target’s expansion into hemp THC beverages across more than 300 stores is a major retail signal just months before a reported federal THC cap is set to take effect. The bigger lesson for operators is that inventory planning, supplier contracts, tax pressure, and product compliance now matter more than the hype around category growth.
280E Tax Relief Could Be Real But Cannabis Operators Should Stay Careful
The federal Schedule III order may open the door to major 280E tax relief for cannabis operators, but the scope is still unclear. The bigger lesson is that tax strategy, amended returns, debt planning, and clean records matter now more than ever.
Disclaimer: All content on this site is for informational and educational purposes only. We share news, insights, and our own interpretations but do not claim ownership of third-party content, always crediting original sources with links. Views expressed in shared content do not necessarily reflect our own. For accurate and current information, please consult the original publisher.
Ready to review your cannabis coverage?
Call us on (323)905-3396
or growth@cannashield.io

Trulieve and Cronos have each gained roughly 27 percent in 2026 while reporting stronger operating results. The broader signal is that public market attention is increasingly rewarding cash generation, improving margins, liquidity, and measurable revenue growth.